Preview this article:
Zoom in

High ceftaroline non-susceptibility in isolated from acute skin infections in 15 tertiary hospitals in China, Page 1 of 1

| /docserver/preview/fulltext/jmm/62/3/496_jmm052522-1.gif

There is no abstract available for this article.
Use the preview function to the left.


Article metrics loading...

Loading full text...

Full text loading...



  1. CLSI ( 2009;). Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 8th edn; Approved Standard. M7-A8. . Wayne, PA:: Clinical and Laboratory Standards Institute;.
  2. CLSI ( 2012;). Performance Standards for Antimicrobial Susceptibility Testing; 22nd Informational Supplement. M100-S22. . Wayne, PA:: Clinical and Laboratory Standards Institute;.
  3. Jones R. N., Mendes R. E., Sader H. S.. ( 2010;). Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study. . J Antimicrob Chemother 65: (Suppl. 4), iv17–iv31. [CrossRef][PubMed]
    [Google Scholar]
  4. Richter S. S., Heilmann K. P., Dohrn C. L., Riahi F., Costello A. J., Kroeger J. S., Biek D., Critchley I. A., Diekema D. J., Doern G. V.. ( 2011;). Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009. . Antimicrob Agents Chemother 55:, 4154–4160. [CrossRef][PubMed]
    [Google Scholar]
  5. Saravolatz L. D., Stein G. E., Johnson L. B.. ( 2011;). Ceftaroline: a novel cephalosporin with activity against methicillin-resistant Staphylococcus aureus. . Clin Infect Dis 52:, 1156–1163. [CrossRef]z[PubMed]
    [Google Scholar]

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error